CME Exam #112

Choose the best response to each question listed below: 1. Which one of the following is true? a) Topical agents are generally less teratogenic than systemic agents and tend to fall into category C or D rather than X. b) Because it is rated category C, cyclosporine is less likely to cause serious birth defects than the X-rated agent fluorouracil. c) Because retinoids are inherently teratogenic, they are unconditionally X-rated. d) The topical agent tazarotene is the only retinoid mentioned that is included in category C. 2. Successful risk management a) involves constant feedback and reassessment. b) consists in selecting a previously successful strategy and persevering until momentum begins to build. c) is best developed from statistical models, not trial and error. d) begins with an analysis of the implemented strategy. 3. Which one of the following is not new to the isotretinoin Pregnancy Prevention Program? a) Patients must return to the office each month to qualify for their next prescription. b) Isotretinoin prescriptions cannot be filled by telephone or electronically. c) Prescriptions are limited to 30 days, without refills. d) Pharmacists will only fill prescriptions within 7 days of the qualification date. 4. Which one of the following is a voluntary, rather than required, element of S.M.A.R.T. for pharmacists? a) enclosing medication guides with prescriptions b) not accepting prescriptions without qualification stickers c) filling prescriptions within 7 days of the qualification date d) verification by telephone of the authenticity of qualification stickers 5. Where would you find information on performing pregnancy tests? a) in the S.M.A.R.T. Guide to Best Practices for prescribers b) in the Be Smart, Be Safe, Be Sure booklet for female patients c) in the Letter of Understanding for prescribers d) all of the above 6. What duties would you expect your pregnancy prevention program coordinator to perform? a) filling out qualification stickers and affixing them to prescriptions b) getting in touch with patients for monthly follow-up visits c) filling out the information/consent and informed consent/agreement forms with male, as well as female, patients d) providing birth control to patients 7. Which one of the following components would most likely be used during a prospective isotretinoin patient’s initial visit to your office? a) qualification checklist b) prescriber checklist c) continuation/progress notes d) prescription pad 8. Which one of the following birth control regimens is unacceptable within the Be Smart, Be Safe, Be Sure program? a) progestin-only pill and male latex condom with spermicide b) male latex condom with vasectomy c) combination pill and cervical cap with spermicide d) vaginal contraceptive ring and a diaphragm with spermicide 9. Which one of the following is not included among the four female qualifications for receiving isotretinoin? a) Patients must use their chosen two forms of contraception for at least 1 month before the initiation of isotretinoin therapy, during the entire period of therapy and for 1 month following the discontinuation of therapy. b) Patients must have been informed of the purpose and importance of participating in the Accutane Survey and be given a chance to enroll. c) Patients must have had negative results on two pregnancy tests performed during the first 5 days of consecutive periods or 11 days after the last unprotected act of sexual intercourse, whichever comes later. d) Counseling about contraception and behaviors associated with an increased risk of therapy must be repeated monthly. 10. In addition to the Accutane Survey, there is a second objective measure of the success of the Accutane Pregnancy Prevention and Risk Management Program: an independent review to determine the use of a) urine pregnancy tests b) qualification stickers c) acceptable contraceptive regimens d) the Be Smart, Be Safe, Be Sure booklet